Brief: Diamyd's Retogatein Delays Insulin Requiring Type-1 Diabetes For More Than 5 Years
24/09/2026 14:21
BRIEF-Diamyd's Retogatein Delays Insulin Requiring Type-1 Diabetes For More Than 5 Years Sept 24 (Reuters) - Diamyd Medical AB DMYDb.ST:
DIAMYD'S RETOGATEIN DELAYS INSULIN REQUIRING TYPE-1 DIABETES FOR MORE THAN 5 YEARS
RETOGATEIN DELAYS MEDIAN TIME TO STAGE 3 DIABETES TO 9.0 YEARS VERSUS 3.4 YEARS PLACEBO
Source text: ID:nWkr6wDRp3
Further company coverage: [DMYDb.ST]
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))